Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Trichoscopy is useful for diagnosing hair-pulling disorder.

Trichoscopy can reliably distinguish between alopecia areata and trichotillomania.

Thorough patient interviews are crucial to identify self-inflicted hair loss.

Hair loss patients may often have Body Dysmorphic Disorder, and proper psychological assessment and treatment can help.

Educating patients on phototrichogram increased satisfaction in androgenetic alopecia treatment.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

Finasteride reduces gambling symptoms in Parkinson's patients.

Trichotillomania is a chronic condition where people uncontrollably pull out their hair, often starting in childhood.

Astrotactin proteins are important for brain and skin development and are linked to several neurodevelopmental disorders.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Treating scalp issues in hair-pulling disorder helps hair regrow and reduces itch.

Ginsenoside Rg3 combined with minoxidil was more effective in treating hair loss in mice.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Sodium valproate is effective in treating epilepsy, especially in patients who don't respond to other medications.

Stopping tight hairstyles can prevent and reduce traction alopecia.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Skin changes can indicate starvation and nutritional deficiencies in anorexia nervosa.

Psychological factors play a significant role in developing alopecia areata.

Eating disorders like anorexia and bulimia cause skin problems, and dermatologists can help detect these disorders early for better treatment outcomes.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

People with androgenetic alopecia have more personality disorders and mental health symptoms; treatment may help.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

Two siblings both had a rare case of alopecia areata at the same time.